10 AI-generated high-yield questions by our AI engine
Overview & Epidemiology
Fibrous dysplasia (FD) is a benign skeletal condition in which normal medullary bone is replaced by abnormal fibrous tissue containing poorly mineralised woven bone trabeculae. It results from a post-zygotic activating mutation in the GNAS gene (encoding the Gs-alpha subunit of G-protein), which leads to unregulated osteoblastic differentiation and abnormal bone production. Despite being non-hereditary, fibrous dysplasia can cause significant skeletal deformity, pain, and pathological fractures, particularly in the proximal femur.
GNAS gene mutation (Arg201His or Arg201Cys): activating somatic mutation; occurs post-zygotically — severity and distribution depends on timing of mutation during embryogenesis (mosaic distribution)
Monostotic FD (70–80%): single bone involved; most commonly proximal femur, tibia, ribs, skull base, facial bones; discovered incidentally or after fracture
Polyostotic FD (20–30%): multiple bones; typically unilateral (hemimelic) distribution; more severe deformity; diagnosed in childhood
McCune-Albright syndrome: polyostotic FD + café-au-lait spots (coast of Maine borders) + endocrine hyperfunctioning (precocious puberty most common); café-au-lait spots in McCune-Albright are large, irregular, with jagged borders — distinct from neurofibromatosis spots which have smooth borders
Malignant transformation: rare (<1% in monostotic; up to 4% in polyostotic; higher post-radiation) — most commonly to osteosarcoma; rapid growth or sudden pain warrants biopsy
Pathology
Medullary bone replaced by cellular fibrous stroma containing irregularly shaped woven bone trabeculae without osteoblastic rimming
Classic histological description: "Chinese characters" or "alphabet soup" pattern — curved, irregularly shaped woven bone trabeculae within cellular fibrous stroma; absence of osteoblastic rimming is key
Cartilage islands: present in some lesions (fibrocartilaginous dysplasia variant) — do not indicate malignancy
Affected bone: cortex thinned but usually intact; medullary cavity expanded; bone structurally weak and deformable
The abnormal fibrous tissue cannot mineralise normally — this is why the bone remains structurally weak throughout life and deforms under load
Radiological Features
Ground-glass matrix: classic radiological appearance — homogeneous, hazy density of affected medullary bone resembling frosted glass; reflects the poorly mineralised fibrous tissue replacing normal bone
Well-defined lesion with narrow zone of transition; endosteal scalloping; cortex thinned but generally intact; no periosteal reaction (unless fracture)
Expansile lesion with cortical thinning — characteristic "rind" of thinned cortex around ground-glass interior
Shepherd crook deformity: characteristic varus deformity of the proximal femur — repeated microfractures and plastic deformity of the femoral neck cause progressive varus, eventually producing a hook-shaped proximal femur resembling a shepherd crook; almost pathognomonic of fibrous dysplasia involving the proximal femur
Bone scan: intense uptake in affected areas — useful for mapping extent of polyostotic disease
MRI: variable signal (low T1; variable T2 depending on proportion of fibrous tissue vs cartilage vs cystic change); useful for assessing cortical integrity and soft tissue involvement
Clinical Presentation
Wide spectrum from asymptomatic (incidental finding) to severe deformity with recurrent fractures and chronic pain
Proximal femur: most clinically significant location — progressive varus deformity (shepherd crook), limb length discrepancy, pathological fractures of the femoral neck; Trendelenburg gait from coxa vara
Facial involvement: facial asymmetry, proptosis, visual compromise, hearing loss from skull base/orbital involvement; lion face (leontiasis ossea) in severe polyostotic disease
Biochemistry: usually normal; elevated alkaline phosphatase in extensive polyostotic disease; phosphate wasting in some — FGF23 elevated (similar mechanism to XLH)
McCune-Albright: girls present with vaginal bleeding and breast development before age 8 years (precocious puberty); assess with pelvic ultrasound and endocrine evaluation
Worsening during pregnancy: FD lesions may enlarge and become more painful during pregnancy — oestrogen-responsive pathology
Management — Non-Operative
Observation: asymptomatic monostotic disease with no deformity or fracture risk — observe with serial radiographs; many lesions stabilise at skeletal maturity
Bisphosphonates (pamidronate IV): reduce pain and bone turnover in FD; some evidence of radiological improvement; do NOT cure FD but can reduce fracture pain and ALP; most evidence for IV pamidronate — oral bisphosphonates less well studied in FD
Pain management: NSAIDs; bisphosphonates; neuropathic agents for bone pain; opioids for acute fracture pain
Endocrine management in McCune-Albright: aromatase inhibitors or testolactone for precocious puberty; endocrinology co-management essential
Activity modification: avoid high-impact activities that stress weakened bones; physiotherapy to optimise gait mechanics and muscle strength
Management — Surgical
Surgical intervention is indicated for pathological fractures, impending fractures, progressive deformity, and painful lesions failing conservative management. The fundamental principle of surgical management differs from standard fracture fixation.
Key surgical principle: FD bone does not remodel normally — bone graft placed into FD lesions is resorbed and replaced by abnormal fibrous tissue; autograft and allograft behave identically poorly in FD cavities; cortical allograft slightly better than cancellous
PMMA cement preferred over bone graft in FD — cement is not remodelled and provides durable fill; however, cement should be combined with internal fixation for structural support
Proximal femur FD (shepherd crook deformity):
Scenario
Surgical Management
Impending fracture without deformity
Prophylactic intramedullary nail (cephalomedullary nail); curettage and cement optional
Femoral neck fracture
Internal fixation with dynamic hip screw or cephalomedullary nail; curettage if accessible
Established shepherd crook deformity
Valgus osteotomy of proximal femur + intramedullary fixation (long nail spanning lesion); curettage and cement of proximal femur lesion; correct varus mechanically
Tibial or other long bone lesion
Intramedullary nail or plate fixation; curettage optional; cement or allograft cortical strut
Intramedullary nailing is preferred over plating for FD — spanning the entire lesion with an IM nail provides superior load-sharing and reduces fracture risk at stress risers beyond the implant
Curettage alone without fixation: only for small contained lesions in non-weight-bearing bones; not sufficient for weight-bearing long bones
Growing children: use flexible nails or fixation that can be revised; account for ongoing growth
Consultant-Level Considerations
Avoid radiation: post-radiation sarcomatous transformation is a well-documented risk in FD — radiation should never be used; treat with surgery and medical management only
Malignant transformation in FD: sudden increase in pain or rapid radiological change in a known FD lesion = biopsy urgently; osteosarcoma is most common secondary malignancy; fibrosarcoma and undifferentiated pleomorphic sarcoma also described; overall rate <1% monostotic, higher polyostotic
Phosphate wasting in FD: FGF23 produced by abnormal stromal cells → renal phosphate wasting → secondary rickets-like picture; in extensive polyostotic disease this can be clinically significant; monitor renal tubular phosphate handling; treat with phosphate supplementation ± calcitriol as in XLH
Bisphosphonate use caution: bisphosphonates inhibit osteoclast activity — theoretically beneficial but some evidence they harden FD bone and make surgical curettage more technically difficult; plan surgery before or early in bisphosphonate course if surgical intervention anticipated
Craniofacial FD: managed by craniofacial surgeons; surgical debulking for cosmesis or functional compromise (visual loss, airway); timing controversial — stabilisation at skeletal maturity preferred before surgery as lesions may grow until then; optic canal decompression is urgent if visual acuity threatened
Exam Pearls
GNAS activating mutation (Gs-alpha); somatic, post-zygotic; mosaic distribution; not hereditary
Ground-glass matrix on X-ray = classic fibrous dysplasia appearance
Shepherd crook deformity: varus proximal femur from repeated microfractures; almost pathognomonic of proximal femoral FD
10 AI-generated high-yield questions by our AI engine
References
Bianco P et al. Fibrous dysplasia. N Engl J Med. 2001;344(18):1381–1389.
DiCaprio MR, Enneking WF. Fibrous dysplasia: pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005;87(8):1848–1864.
Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 1994;343(8903):953–954.
Collins MT et al. An epidemiological approach to fibrous dysplasia and the McCune-Albright syndrome. Orphanet J Rare Dis. 2012.
Chapurlat RD, Meunier PJ. Fibrous dysplasia of bone. Baillieres Best Pract Res Clin Rheumatol. 2000;14(2):385–398.
Leet AI, Collins MT. Current approach to fibrous dysplasia of bone and McCune-Albright syndrome. J Child Orthop. 2007;1(1):3–17.
Ippolito E et al. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B. 2003.
Campbells Operative Orthopaedics. 14th Edition. Elsevier.
Orthobullets — Fibrous Dysplasia.
Enneking WF, Gearen PF. Fibrous dysplasia of the femoral neck: treatment by cortical bone grafting. J Bone Joint Surg Am. 1986;68(9):1415–1422.